NEW DELHI: Bharat Biotech s COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
NEW DELHI: Bharat Biotech s COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
An expert committee constituted by the Central Drug Standard Control Organisation has approved the marketing of hydroxyurea for the treatment of Sickle Cell Anemia (SCA). The approval, researchers said, legalizes the drug usage in standard doses for SCA treatment, while allowing the designing of various formulations of smaller dose sizes that promise higher compliance rates in
Bengaluru: Stelis Biopharma Limited, the biotech division of Strides Pharma Science Limited, has commissioned its large-scale fully integrated vaccine manufacturing facility at Bengaluru, India.The.